Search any private company and open it for the full read — what they raised, how they compare to peers, and who's behind it.
| Company | Latest stage | Raised | Modeled value est. | |
|---|---|---|---|---|
| Liquid BioScience, Inc. · ALISO VIEJO | Series B | $40.0M | $1.6B | |
| Redpoint Bio CORP · PHILADELPHIA | Series B | $40.0M | $1.6B | |
| Pandion Therapeutics Holdco LLC · CAMBRIDGE | Series B | $40.0M | $1.6B | |
| BioAtla,LLC · SAN DIEGO | Series B | $47.9M | $1.5B | |
| Amphivena Therapeutics, Inc. · SOUTH SAN FRANCISCO | Series B | $65.2M | $1.5B | |
| Tracon Pharmaceuticals, Inc. · San Diego | Series B | $57.7M | $1.5B | |
| Ocular Therapeutix, Inc · BEDFORD | Series B | $81.0M | $1.5B | |
| Cardiaq Valve Technologies Inc · IRVINE | Series B | $77.2M | $1.5B | |
| Ion Torrent Systems Inc · GUILFORD | Series B | $59.9M | $1.5B | |
| Insilico Medicine Cayman TopCo · HONG KONG | Series B | $36.8M | $1.5B | |
| Level Access Holdings, Inc. · VIENNA | Series B | $40.0M | $1.5B | |
| PhotoThera Inc · CARLSBAD | Series B | $36.4M | $1.4B | |
| Scholar Rock LLC · CAMBRIDGE | Series B | $36.3M | $1.4B | |
| Taligen Therapeutics Inc · CAMBRIDGE | Series B | $62.1M | $1.4B | |
| Tetra Discovery Partners, Inc. · GRAND RAPIDS | Series B | $40.5M | $1.4B | |
| ECM Therapeutics, Inc. · WARRENDALE | Series B | $35.2M | $1.4B | |
| CyberGRX, Inc. · DENVER | Series B | $85.0M | $1.4B | |
| Purigen Biosystems, Inc. · Pleasanton | Series B | $61.9M | $1.4B | |
| LP Investors, LLC · FAIRFIELD | Series B | $40.0M | $1.4B | |
| Visterra, Inc. · CAMBRIDGE | Series B | $82.4M | $1.4B | |
| Evolus, Inc. · Newport Beach | Series B | $40.5M | $1.4B | |
| Celltex Therapeutics Corp · HOUSTON | Series B | $34.1M | $1.4B | |
| Oligasis, LLC · Palo Alto | Series B | $35.8M | $1.3B | |
| Palo Alto Networks Inc · SUNNYVALE | Series B | $37.3M | $1.3B | |
| Celator Pharmaceuticals Inc · PRINCETON | Series B | $63.5M | $1.3B | |
| Recombinetics, Inc · St. Paul | Series B | $54.7M | $1.3B | |
| Glycomimetics Inc · Gaithersburg | Series B | $54.3M | $1.3B | |
| Mersana Therapeutics Inc · CAMBRIDGE | Series B | $93.7M | $1.3B | |
| Atox Bio Inc. · NESS ZIONA | Series B | $35.1M | $1.3B | |
| Valeritas Holdings Inc. · Bridgewater | Series B | $58.2M | $1.3B | |
| Lipocine Inc. · SALT LAKE CITY | Series B | $38.0M | $1.3B | |
| Lucira Health, Inc.Winter 2015 · EMERYVILLE Next generation infectious disease test kits | Series B · Public | $32.5M | $1.3B | |
| Obsidian Therapeutics, Inc. · CAMBRIDGE | Series B | $32.4M | $1.3B | |
| Alector LLC · SAN FRANCISCO | Series B | $32.3M | $1.3B | |
| 1010data, Inc. · NEW YORK | Series B | $35.0M | $1.3B | |
| CARDEAS PHARMA Corp · SEATTLE | Series B | $96.5M | $1.3B | |
| HOOKIPA Pharma Inc. · NEW YORK | Series B | $37.4M | $1.3B | |
| Kythera Biopharmaceuticals Inc · CALABASAS | Series B | $37.4M | $1.3B | |
| CoLucid Pharmaceuticals, Inc. · DURHAM | Series B | $60.0M | $1.3B | |
| Gelesis Inc · Boston | Series B | $37.7M | $1.3B | |
| Prosetta Biosciences Inc. · SAN FRANCISCO | Series B | $31.1M | $1.2B | |
| GigaGen, Inc. · SOUTH SAN FRANCISCO | Series B | $36.1M | $1.2B | |
| ESSA Pharma Inc. · Vancouver | Series B | $56.0M | $1.2B | |
| Vitality Biopharma, Inc. · LOS ANGELES | Series B | $39.5M | $1.2B | |
| Certified Inc. · BOCA RATON | Series B | $40.0M | $1.2B | |
| Decisions, LLC · CHESAPEAKE | Series B | $40.0M | $1.2B | |
| Fugoo Corp · CHINO | Series B | $40.0M | $1.2B | |
| PlanSource Holdings, Inc. · ORLANDO | Series B | $40.0M | $1.2B | |
| Pymetrics, Inc. · New York | Series B | $46.6M | $1.2B | |
| Saltside Technologies Saltside Technologies raises $40m from Kinnevik, Hillhouse | Series B | $40.0M | $1.2B | |
| Suvoda LLC · CONSHOHOCKEN | Series B | $40.0M | $1.2B | |
| Universal Recognition Token, Inc. · NEW YORK | Series B | $40.0M | $1.2B | |
| Visual Lease, LLC · WOODBRIDGE | Series B | $40.0M | $1.2B | |
| Transphorm, Inc. · Goleta | Series B | $246.8M | $1.2B | |
| Skyhigh Networks, Inc. · Cupertino | Series B | $46.5M | $1.2B | |
| SmartRecruiters, Inc. · SAN FRANCISCO | Series B | $95.0M | $1.2B | |
| Misfit Wearables Corp · BURLINGAME | Series B | $63.0M | $1.2B | |
| Petra Solar Inc · South Plainfield | Series B | $40.0M | $1.2B | |
| Anomali Inc · REDWOOD CITY | Series B | $40.0M | $1.2B | |
| Veracode Inc · BURLINGTON | Series B | $95.1M | $1.2B | |
| Hired, Inc. · SAN FRANCISCO | Series B | $57.5M | $1.2B | |
| Litify Inc. · BROOKLYN | Series B | $43.7M | $1.2B | |
| Docutech Transfer, LLC · IDAHO FALLS | Series B | $39.9M | $1.2B | |
| Kinnser Software, Inc. · AUSTIN | Series B | $39.9M | $1.2B | |
| Cellular Biomedicine Group, Inc. · CUPERTINO | Series B | $40.5M | $1.2B | |
| LEADER SKY TRADING Ltd · SHANGHAI | Series B | $38.5M | $1.2B | |
| Plaid Technologies, Inc. · SAN FRANCISCO | Series B | $39.8M | $1.2B | |
| Crown Bioscience, Inc · SANTA CLARA | Series B | $87.1M | $1.2B | |
| Altor Bioscience Corp · MIRAMAR | Series B | $80.1M | $1.2B | |
| 360fly, Inc. · PITTSBURGH | Series B | $69.9M | $1.2B | |
| Jask Labs Inc. · AUSTIN | Series B | $35.1M | $1.2B | |
| Stevenson Aggregator, LP · NEW YORK | Series B | $39.5M | $1.2B | |
| LogRhythm, Inc. · Boulder | Series B | $111.3M | $1.2B | |
| Stem Cell Therapeutics Corp · Toronto | Series B | $30.3M | $1.2B | |
| Magnachip Semiconductor Llc · LUXEMBOURG | Series B | $39.5M | $1.2B | |
| Iqms · PASO ROBLES | Series B | $74.5M | $1.2B | |
| Exosome Diagnostics, Inc. · Waltham | Series B | $90.9M | $1.2B | |
| Trius Therapeutics Inc · San Diego | Series B | $49.3M | $1.2B | |
| Emisphere Technologies Inc · Roseland | Series B | $49.7M | $1.2B | |
| Aquesys Inc · ALISO VIEJO | Series B | $49.5M | $1.2B | |
| Atritech Inc · Plymouth | Series B | $30.0M | $1.2B | |
| Intercept Pharmaceuticals Inc · NEW YORK | Series B | $45.0M | $1.2B | |
| Lacerta Therapeutics, Inc. · ALACHUA | Series B | $30.5M | $1.2B | |
| Tenex Health, Inc. · ROCHESTER | Series B | $57.4M | $1.2B | |
| Madrigal Pharmaceuticals, Inc. · WEST CONSHOHOCKEN | Series B | $35.0M | $1.2B | |
| Palatin Technologies Inc · CRANBURY | Series B | $35.0M | $1.2B | |
| Slayback Pharma Ltd Liability Co · PRINCETON JUNCTION | Series B | $35.0M | $1.2B | |
| X4 Pharmaceuticals, Inc. · Cambridge | Series B | $73.2M | $1.2B | |
| Humu, Inc. · MOUNTAIN VIEW | Series B | $49.5M | $1.2B | |
| Trackonomy Systems, Inc. · SANTA CLARA | Series B | $49.2M | $1.2B | |
| Ruby Receptionists, Inc. · PORTLAND | Series B | $38.8M | $1.2B | |
| Vistronix Intelligence & Technology Solutions, LLC · RESTON | Series B | $56.1M | $1.2B | |
| GuiaBolso (Cayman), Ltd. · GRAND CAYMAN | Series B | $58.0M | $1.2B | |
| Ziften Technologies, Inc. · AUSTIN | Series B | $38.7M | $1.2B | |
| Elastic Path Software Inc. · VANCOUVER | Series B | $32.2M | $1.2B | |
| Avid Radiopharmaceuticals, Inc. · PHILADELPHIA | Series B | $63.1M | $1.2B | |
| Spin Memory, Inc. · FREMONT | Series B | $38.5M | $1.2B | |
| Hazelcast, Inc. · San Mateo | Series B | $55.1M | $1.2B | |
| Barosense Inc · REDWOOD CITY | Series B | $56.9M | $1.2B | |
| Symic Holdings, LLC · EMERYVILLE | Series B | $72.4M | $1.2B |